Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

(T14)
  Report
Delayed Singapore Stock Exchange  -  04:04:46 2023-01-30 am EST
1.090 USD   -0.91%
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Appoints Mao Weiwen as Non-Executive and Non-Independent Director
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Wong Gang as Independent and Non-Executive Director
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(SHSE:600329) dropped from Shanghai Stock Exchange Health Care Sector Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisionsFunds 
Event chart TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Upcoming events on TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
03/31/23 FY 2022 Earnings Release
Past events on TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
12/30/22 | 01:00am Extraordinary Shareholders Meeting
10/28/22 | 06:50am Q3 2022 Earnings Release
08/12/22 | 06:36am Interim 2022 Earnings Release
12/10/21 | 01:00am Extraordinary Shareholders Meeting
10/29/21 | 05:00am Q3 2021 Earnings Release
09/06/21 | 02:15am Extraordinary Shareholders Meeting
08/13/21 | 05:30am Interim 2021 Earnings Release
05/17/21 | 01:30am Annual General Meeting
04/29/21 | 05:18am Q1 2021 Earnings Release
03/30/21 | 05:13am FY 2020 Earnings Release
Past dividends on TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
05/24/22 Annual 0.1027 SGD
06/15/21 Annual 0.06198 SGD
06/15/20 Annual 0.058761 SGD
07/01/19 Annual 0.04323 SGD
06/28/18 Annual 0.2 CNY
06/28/17 Final Payment 0.15 CNY
12/05/16 Interim Payment 0.1 CNY
06/24/16 Annual 0.15 CNY
05/22/15 Annual 0.15 CNY
07/04/14 Final Payment 0.05 CNY
Annual results
Fiscal Period : December201720182019202020212022
Sales
M CNY
Released
Forecast
Spread
5 689
6 101
-6,7%
6 359
6 305
0,85%
6 994
7 026
-0,46%
6 604
7 727
-15%


 
 
7 361
 
Operating income
(EBITDA)
M CNY
Released
Forecast
Spread
495
518
-4,4%
562
661
-15%
657
653
0,61%


 


 
 
942
 
Operating profit
(EBIT)
M CNY
Released
Forecast
Spread
526
415
27%
642
582
10%
556
722
-23%
785
826
-4,9%


 
 
1 041
 
Pre-Tax Profit
(EBT)
M CNY
Released
Forecast
Spread
531
524
1,3%
641
630
1,7%
743
721
3,1%
768
825
-6,9%


 
 
1 042
 
Net income
M CNY
Released
Forecast
Spread
476
455
4,6%
562
548
2,5%
626
634
-1,3%
662
724
-8,6%
769

 
 
886
 
EPS
SGD
Released
Forecast
Spread
0,13
0,12
7,0%
0,15
0,15
-3,4%
0,16
0,16
0,59%


 


 
 

 
Announcement Date03/30/201803/29/201904/17/202003/30/202103/30/2022-
Upcoming sector events for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
More events
Past sector events for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise